Trial Details

COMPLETED
Basic Information
Clinical ID c4602
Identifier NCT00269412
Trial Title Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Irritable Bowel Syndrome
Interventions DRUG: Rifaximin
Participant Information
Sponsor Bausch Health Americas, Inc.
City Scottsdale
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2005-12
Primary Completion Date 2007-08
Completion Date 2008-09